| |
|
|
|
Five Prime Therapeutics Inc.  
|
|
4.03 0.06 (0.02%) |
09-18 16:00 |
|
Open: |
3.97 |
Pre close: |
3.97 |
Target:
|
5.40
|
|
High: |
4.055 |
Low: |
3.86 |
Resistance:
|
4.62
5.18
|
|
Volume: |
259,313 |
Market Cap: |
148M |
Support:
|
3.72
3.10
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.01
 |
MACD |
MACD(12,26):
|
-0.31 |
|
MA(20): |
4.24  |
Signal(12,26,9): |
-0.35 |
|
MA(100): |
4.98 |
Stochastic Oscillator |
%K(14,3):
|
40.55 |
|
MA(250): |
4.37 |
%D(3): |
31.96 |
|
Average Volume(K) |
3-Month: |
35429
|
52-Week |
High:
|
7.34 |
|
10-Days: |
22869 |
Low: |
1.75 |
|
RSI |
RSI(14):
|
38.63 |
Change(%): |
-25.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.967 |
Return on Equity (ttm) |
-64.0 |
Shares Out. (M) |
36.63 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-27.7 |
Shares Float (M) |
26.19 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.06 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
2.7 |
% Held by Institutions |
73.55 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
-2.538 |
Shares Short (K) |
1660 |
|
Book Value (p.s.) |
3.380 |
EBITDA (p.s.) |
-2.769 |
P/E |
-1.36 |
|
Sales Per Share |
0.492 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.19 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-93.60 |
P/S |
8.19 |
|
Operating Margin |
-588.34 |
Levered Free Cash Flow
(M) |
-48.63 |
P/CF |
-1.58 |
|
|
|
|
|
|
